/PRNewswire/ — SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co.,…
SK Life Science Presents Cenobamate Research at the 2024 American Epilepsy Society (AES) Annual Meeting
